Advagene Biopharma Co., Ltd. (TPEX:6709)
25.55
-0.30 (-1.16%)
Apr 20, 2026, 1:15 PM CST
53.45% (1Y)
| Market Cap | 1.51B +17.0% |
| Revenue (ttm) | n/a |
| Net Income | -68.29M |
| EPS | -1.15 |
| Shares Out | 59.38M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 102,600 |
| Average Volume | 72,208 |
| Open | 25.70 |
| Previous Close | 25.85 |
| Day's Range | 25.50 - 25.80 |
| 52-Week Range | 15.75 - 41.00 |
| Beta | 0.85 |
| RSI | 24.62 |
| Earnings Date | May 14, 2026 |